Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Der

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinasesJ K Westwick, A D Cox, C J Der, et al.
Oncogene|October 20, 2009
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signalingA B Hanker, N Mitin, R S Wilder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophilsL A Quilliam, H Mueller, B P Bohl, et al.
The Journal of Biological Chemistry|June 27, 1998
Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-JunJ K Westwick, R J Lee, Q T Lambert, et al.
Oncogene|May 13, 1999
TC21 and Ras share indistinguishable transforming and differentiating activitiesS M Graham, S M Oldham, C B Martin, et al.
Oncogene|August 22, 2000
G2A is an oncogenic G protein-coupled receptorI E Zohn, M Klinger, X Karp, et al.
Oncogene|May 22, 2001
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathwaysC B Martin, G M Mahon, M B Klinger, et al.
The Prostate|January 1, 1988
Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma systemD B Cooke, V E Quarmby, P Petrusz, et al.
Gastroenterology|August 28, 1999
Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptidesN Sizemore, A D Cox, J A Barnard, et al.
The Journal of Biological Chemistry|April 1, 2000
Vav2 is an activator of Cdc42, Rac1, and RhoAK Abe, K L Rossman, B Liu, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinasesJ K Westwick, A D Cox, C J Der, et al.
Oncogene|October 20, 2009
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signalingA B Hanker, N Mitin, R S Wilder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1991
Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophilsL A Quilliam, H Mueller, B P Bohl, et al.
The Journal of Biological Chemistry|June 27, 1998
Transforming potential of Dbl family proteins correlates with transcription from the cyclin D1 promoter but not with activation of Jun NH2-terminal kinase, p38/Mpk2, serum response factor, or c-JunJ K Westwick, R J Lee, Q T Lambert, et al.
Oncogene|May 13, 1999
TC21 and Ras share indistinguishable transforming and differentiating activitiesS M Graham, S M Oldham, C B Martin, et al.
Oncogene|August 22, 2000
G2A is an oncogenic G protein-coupled receptorI E Zohn, M Klinger, X Karp, et al.
Oncogene|May 22, 2001
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathwaysC B Martin, G M Mahon, M B Klinger, et al.
The Prostate|January 1, 1988
Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma systemD B Cooke, V E Quarmby, P Petrusz, et al.
Gastroenterology|August 28, 1999
Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptidesN Sizemore, A D Cox, J A Barnard, et al.
The Journal of Biological Chemistry|April 1, 2000
Vav2 is an activator of Cdc42, Rac1, and RhoAK Abe, K L Rossman, B Liu, et al.
Pageof 18